Paracetamol Sopharma (Paracetamol)

Paracetamol Sopharma is an analgesic and antipyretic that acts on pain and fever pathways.

• Headache: provides relief from mild to moderate tension‑type headaches.
• Fever: reduces elevated body temperature associated with viral or bacterial infections.
• Musculoskeletal pain: eases aches in muscles and joints such as back‑pain or minor sprains.
• Dental pain: alleviates discomfort following dental procedures or toothache.
• Cold‑related discomfort: helps manage aches and fever that accompany common colds.

• Paracetamol exerts its effect primarily by inhibiting the cyclooxygenase (COX) enzymes in the central nervous system, especially COX‑2, which lowers prostaglandin synthesis. The reduced prostaglandin levels diminish the hypothalamic set‑point for temperature regulation and modulate pain signalling pathways, providing analgesic and antipyretic actions without significant peripheral anti‑inflammatory activity.

Paracetamol Sopharma is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild stomach upset may be reported.
• Rash: occasional skin redness or mild itching.
• Elevated liver enzymes: transient increase detected in blood tests.

Serious or Rare Side Effects

• Hepatotoxicity: risk of liver injury with overdose or chronic high‑dose use.
• Stevens‑Johnson syndrome: rare severe skin reaction.
• Anaphylaxis: extremely rare allergic response requiring immediate medical attention.
• Blood disorders: rare cases of thrombocytopenia or neutropenia.

When using Paracetamol Sopharma, consider the following safety measures.

• Dose limitation: do not exceed the maximum daily amount recommended by a healthcare professional.
• Liver disease: avoid use or adjust dose in patients with existing hepatic impairment.
• Alcohol consumption: limit intake as alcohol can increase hepatotoxic risk.
• Concomitant medications: review all other products containing paracetamol to prevent accidental overdose.
• Pregnancy and lactation: use only under medical supervision during pregnancy or while breastfeeding.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Paracetamol Sopharma may interact with several medicines; monitoring is advised.

Major Interactions (Avoid)

• Warfarin: increased anticoagulant effect may raise bleeding risk.
• Isoniazid: combined use can heighten potential for liver toxicity.

Moderate Interactions (Monitor Closely)

• Antiepileptics (e.g., carbamazepine, phenytoin): may reduce paracetamol plasma levels.
• Rifampicin: may increase metabolism leading to lower efficacy.
• HIV protease inhibitors: can alter hepatic processing of paracetamol.